Nephros NEPH
NASDAQ NEPH
$3.31 +0.24 (+7.82%)
At close: Nov 12, 2026 · 4:00 PM EST

Nephros (NEPH) Gains from Sales and Divestitures (2012 - 2018)

Updated

Nephros' Gains from Sales and Divestitures was $5,000 in FY2024.

Analysis

Nephros (NEPH) Gains from Sales and Divestitures (2012 - 2018) Analysis & Trends

From FY2012 onward, Nephros has reported Gains from Sales and Divestitures for 4 years.

  • The FY2024 figure marks the highest annual Gains from Sales and Divestitures since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn
3 Danaher 163.29 Bn 142.96 Bn 3.84 Bn
4 Intuitive Surgical 152.47 Bn 132.89 Bn 2.08 Bn
5 Medtronic 131.95 Bn 97.47 Bn 6.34 Bn
6 Stryker 119.59 Bn 105.78 Bn 4.25 Bn
7 Boston Scientific 64.18 Bn 59.61 Bn 3.43 Bn
8 Edwards Lifesciences 60.93 Bn 44.24 Bn 1.35 Bn
9 Medline 52.61 Bn 49.74 Bn 1.93 Bn
10 Nephros 35.98 Mn 17.32 Mn 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -10,000.00
Sep 30, 2013 1,000.00
Mar 31, 2013 2,000.00
Dec 31, 2012 55,000.00
API Access

Nephros Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NEPH&period=max&api_key=YOUR_API_KEY